Middle East and Africa Digital Therapeutics Market is Segmented Digital Therapeutics Market is segmented By Product Type (Software, Devices, Others), By Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others), By Sales Channel (Business-to-Business (B2B) (Employer, Healthcare Providers, Payers, Pharmaceutical Companies, Others), Business-to-Consumer (B2C) (Patient, Caregiver)), and By Country (UAE,KSA, Israel) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Middle East and Africa Digital Therapeutics Market Overview
Middle East and Africa Digital Therapeutics Market is expected at a CAGR of 23.4% during the forecast period.
Digital therapeutics is a healthcare solution and treatment option that uses digital technologies to cure patients with medical or psychological problems. It offers a new approach to disease management by using high-quality software and systems to assist patients in monitoring their health conditions at home. These solutions use the internet infrastructure, smartphones, and advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics to customize the treatment to the patient.
The digital therapeutics market includes various products such as telemedicine platforms, apps, wearable devices, and others. Currently, there are many healthcare apps and wearable devices that are easily accessible worldwide.
Middle East and Africa Digital Therapeutics Market Scope
|
Metrics |
Details |
|
CAGR |
23.4% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Product Type, Application, Sales Channel, and Country |
|
Countries Covered |
KSA, UAE, Israel |
|
Largest Country |
UAE |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Middle East and Africa Digital Therapeutics Market Dynamics
Increasing patient demand for digital therapeutics is poised for continued growth.
The growing adoption of technological advancements in digital therapeutics is contributing to the growth of the MEA digital therapeutics market. Healthcare providers and researchers have been working together to develop digital therapeutics for oncology, cardiovascular diseases and others. Manufacturers also focus on developing digital therapeutics with advanced features like big data and artificial intelligence to ensure the best possible design, clinical support and data security.
Furthermore, they manufacture medical products used in digital therapeutics to monitor and track patients' health throughout treatment. The wide range of applications for digital therapeutics, including promoting adherence to prescribed treatments, diets, and exercise regimens, also contribute to the market's growth. With the ongoing development of cutting-edge technologies and increasing patient demand, the market for digital therapeutics is poised for continued growth.
Middle East and Africa Digital Therapeutics Market Segment Analysis
Middle East America and Africa Digital Therapeutics Market is segmented into product type, application, sales channel and country
By Product Type
- Software
- Devices
- Others
By Application
- Diabetes
- Obesity
- Cardiovascular Diseases (CVD)
- Central Nervous System (CNS) Diseases
- Respiratory Diseases
- Smoking Cessation
- Gastrointestinal Disorders (GID)
- Others
By Sales Channel
- Business-to-Business (B2B)
- Employer
- Healthcare Providers
- Payers
- Pharmaceutical Companies
- Others
- Business-to-Consumer (B2C)
- Patient
- Caregiver
By Country
- KSA
- UAE
- Israel
Middle East and Africa Digital Therapeutics Market Regional Analysis
The Middle East and Africa Digital Therapeutics Market can be segmented into KSA, UAE, Israel
The Middle East and Africa accounted for a moderate share of the global market in 2022. However, during the forecast period, the regional market is expected to grow at a healthy CAGR due to the increasing focus of international market participants on capturing the potential of the MEA region. The healthcare infrastructure in the MEA region is improving, and the number of initiatives by the governments of MEA countries in favor of digital healthcare is increasing. Moreover, the growing prevalence of chronic diseases is driving the demand for advanced healthcare solutions. Among the MEA countries, the UAE is expected to hold a significant share of the market during the forecast period. This is due to the large and relatively younger population that presents a substantial target base, rapid urbanization, and digitization. Additionally, ongoing reforms to address inadequate infrastructure and ensure sustainable growth through financial inclusion are expected to have a positive impact on the market.
Major Key Players in the Market
The major players covered in the Middle east and Africa digital therapeutic market report are Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are playing a leading role in the APAC digital therapeutics market
